A major 2026 headline in the excipient world is the rise of Endotoxin-Controlled Excipients (ECE). In 2026, manufacturers are launching specialized portfolios of medical-grade gelatins and collagen peptides that are virtually free of pyrogens (fever-inducing substances). This 2026 focus on "Ultra-Clean" stabilizers is critical for the next generation of vaccines and 3D bioprinting, where even a...